Chemogenomic profiling provides insights into the limited activity of 
irreversible EGFR inhibitors in tumor cells expressing the T790M EGFR 
resistance mutation

Sos, Martin L.; Rode, Haridas B.; Heynck, Stefanie; Peifer, Martin; Fischer, Florian; Klüter, Sabine; Pawar, Vijakumar G.; Reuter, Cecile; Heuckmann, Johannes M.; Weiss, Jonathan; Ruddigkeit, Lars; Rabiller, Matthias; Koker, Mirjam; Simard, Jeffrey R.; Getlik, Matthäus; Yuza, Yuki; Chen, Tzu-Hsiu; Greulich, Heidi; Thomas, Roman K.; Rauh, Daniel

doi:10.1158/0008-5472.CAN-09-3106

Local TagsRelease HistoryDetailsSummary

Chemogenomic profiling provides insights into the limited activity of irreversible EGFR inhibitors in tumor cells expressing the T790M EGFR resistance mutation

Sos, M. L., Rode, H. B., Heynck, S., Peifer, M., Fischer, F., Klüter, S., et al. (2010). Chemogenomic profiling provides insights into the limited activity of irreversible EGFR inhibitors in tumor cells expressing the T790M EGFR resistance mutation. Cancer Research, 70(3), 868-874. doi:10.1158/0008-5472.CAN-09-3106.

Item is Released

show all hide all

Basic

show hide

Item Permalink: https://hdl.handle.net/11858/00-001M-0000-0026-D307-E Version Permalink: https://hdl.handle.net/11858/00-001M-0000-0026-D308-C

Genre: Journal Article

Files

show Files

Locators

show

Creators

show

hide

Creators:
Sos, Martin L.¹, Author
Rode, Haridas B.², Author
Heynck, Stefanie¹, Author
Peifer, Martin¹, Author
Fischer, Florian¹, Author
Klüter, Sabine², Author
Pawar, Vijakumar G.², Author
Reuter, Cecile¹, Author
Heuckmann, Johannes M.¹, Author
Weiss, Jonathan¹, Author
Ruddigkeit, Lars², Author
Rabiller, Matthias², Author
Koker, Mirjam¹, Author
Simard, Jeffrey R.², Author
Getlik, Matthäus², Author
Yuza, Yuki², Author
Chen, Tzu-Hsiu², Author
Greulich, Heidi², Author
Thomas, Roman K.¹, Author
Rauh, Daniel², Author

Affiliations:
1Funktionelle Krebsgenomforschung, Junior Research Groups, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society, ou_2149656
21 Center of Integrated Oncology and Department I of Internal Medicine, University of Köln, Cologne, Germany; 2 Chemical Genomics Centre of the Max Planck Society, Dortmund, Germany; 3 Department of Pediatrics, The Jikei University School of Medicine, Tokyo, Japan; 4 Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 5 Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts; 6 The Broad Institute of MIT and Harvard, Cambridge, Massachusetts, ou_persistent22

Content

show

hide

Free keywords: -

Details

show

hide

Language(s): eng - English

Dates: Date issued: 2010

Publication Status: Issued

Pages: -

Publishing info: -

Table of Contents: -

Rev. Type: Peer

Identifiers: eDoc: 472769
DOI: 10.1158/0008-5472.CAN-09-3106

Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show

hide

Title: Cancer Research

Source Genre: Journal

Creator(s):

Affiliations:

Publ. Info: -

Pages: - Volume / Issue: 70 (3) Sequence Number: - Start / End Page: 868 - 874 Identifier: -